Want to lead a de-stressed life? Quit Facebook, says study

About 100,000 of the estimated million persons in the United States with multiple sclerosis (MS) have a progressive form of the disease, with symptoms worsening over time or following periods of remission.

Cambridge scientists have created a breakthrough material that can sense tiny chemical changes in the body, such as the increased acidity during an arthritis flare-up, and release drugs exactly when and where they're needed.

Researchers have created a revolutionary robotic skin that brings machines closer to human-like touch.

A study analyzing data from nationally representative dietary surveys and mortality data from eight countries (Australia, Brazil, Canada, Chile, Colombia, Mexico, United Kingdom, and United States) shows that premature deaths attributable to consumption of ultraprocessed foods (UPFs) increase significantly according to their share in individuals' total energy intake

Whooping cough, also known as pertussis, was formerly a leading cause of death in children in the United States and around the world before vaccines were introduced in the 1940s.

According to the World Health Organisation, around 3.9 per cent of the global population has had post-traumatic stress disorder (PTSD) at some point in their lives. That figure is greater in the United States, at over 6 per cent.

Adults with congenital heart disease (CHD) can now gain vital insights into their long-term quality of life according to data from the Congenital Heart Initiative (CHI). CHI is the nation's first and largest patient-focused registry for people with CHD, and it recently launched its inaugural research, which included over 4,500 participants from all 50 states.

Scientists at the DZD partner German Institute of Human Nutrition Potsdam-Rehbrucke (DIfE) have now explored whether substantial weight reduction improves metabolic and psychological states, as well as decision-making ability. The findings were reported in the journal Clinical Nutrition.

Researchers from the University of Auckland, Amsterdam University Medical Center, and Cambridge University Hospitals have successfully treated over ten patients with CRISPR/Cas9 technology, with preliminary findings just published in a leading journal.

Researchers from the University of Auckland, Amsterdam University Medical Center, and Cambridge University Hospitals have successfully treated over ten patients with CRISPR/Cas9 technology, with preliminary findings just published in a leading journal.